Tracking TBI: neuromonitoring for brain injuries
UC expert discusses advances in neurocritical care with Albany, Georgia's WALB
The University of Cincinnati's Brandon Foreman, MD, discussed advances in multimodal neuromonitoring with Albany, Georgia's WALB-TV.
Like traditional monitoring of a patient's heart rate, blood pressure and oxygen levels, multimodal neuromonitoring tracks similar brain health data points for patients with traumatic brain injuries. Measurements like blood flow, pressure, oxygen and glucose levels in the brain give actionable information over time when treating patients with severe brain trauma.
"What’s happening in the patient on day one is often very different compared to what’s happening to that patient on day three," said Foreman, associate professor of neurology and associate director of neurocritical care research in the Department of Neurology and Rehabilitation Medicine in UC’s College of Medicine and a UC Gardner Neuroscience Institute physician. "We’re learning a lot about what those patterns look like, how individual they are and how we can treat them in a more precise way tailored to that patient."
Read more about multimodal neuromonitoring work at UC.
Featured photo at top of Foreman reviewing brain data on a monitor. Photo/Andrew Higley/UC Marketing + Brand.
Related Stories
Jacksonville media: New stroke research aims to help predict recovery
April 18, 2023
Jacksonville, Florida television news station WJXT highlighted the VERIFY study being led by University of Cincinnati researchers that will examine if certain biomarkers can predict the likelihood that a patient will recover motor functions following a stroke.
Know Stroke Podcast: UC physician discusses mobile stroke unit
April 28, 2023
The University of Cincinnati's Christopher T. Richards, MD, was a recent guest on the Know Stroke Podcast to discuss mobile stroke units and where research is headed to improve care.
WLWT: UC hosts RESET epilepsy trial
May 3, 2023
WLWT spoke with the University of Cincinnati's Brandon Foreman about a clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.